New Research Offers Hope for Head and Neck Cancer Treatment

Strategic Insights -

Scientists from Michigan State University and Henry Ford Health have been awarded a $3 million grant to study new treatments for patients with head and neck cancer caused by the human papillomavirus (HPV). This cancer type significantly affects patients' quality of life, with symptoms including challenges with speech, swallowing, and even breathing. The researchers aim to develop new solutions, including immunotherapy, to help activate the body's immune system to eliminate this cancer.

Key Takeaways:

  • 25% of head and neck cancers are caused by the human papillomavirus (HPV), a number that is rising sharply.
  • Scientists do not know much about how the virus helps these cancers evade the body's immune defenses.
  • Researchers have identified the MARCHF8 protein as a possible culprit in inhibiting the immune system to kill infected tumor cells.
  • A healthy immune system activates T cells when antigens are detected, but cancer cells frequently inhibit antigen presentation and grow undetected.
  • An estimated 600 to 700 million people worldwide are infected with HPV, and the number of patients needing treatment for head and neck cancer is expected to rise substantially.
  • The researchers' preliminary answers about how to improve the body's detection of these cancer cells were discovered with grants from the Henry Ford + MSU Cancer Seed Funding Program and the MSU Research Foundation.
  • Knockdown of MARCHF8 can significantly boost antitumor immunity, making it a potential new therapeutic target.
  • Findings from this research are intended to reduce the intensity of treatment of HPV-positive head and neck cancers and create a better treatment with fewer side effects.
  • The researchers highly recommend the HPV vaccine for those who can get it.

Statistics:

  • 25% of head and neck cancers are caused by the human papillomavirus (HPV).
  • 600 to 700 million people worldwide are infected with HPV.
  • $3 million: the grant award to study new treatments for patients with head and neck cancer caused by HPV.
  • 25%: the percentage of head and neck cancers that are caused by the human papillomavirus (HPV), a number that is rising sharply.

Sources:

  • Researchers from Henry Ford Health + Michigan State University Health Sciences were awarded a $3 million grant from the National Institute of Dental and Craniofacial Research.
  • The researchers' preliminary answers about how to improve the body's detection of these cancer cells were discovered with grants from the Henry Ford + MSU Cancer Seed Funding Program and the MSU Research Foundation.
  • Image courtesy of the Pyeon lab at Michigan State University